ESTIMATED COMMITMENT TO VACCINATION OF ALMATY CITY POPULATION AGAINST SARS-COV-2
Relevance: The COVID-19 infection caused by the severe acute respiratory syndrome coronavirus (SARS-CoV-2) has rapidly escalated into a pandemic since it was first reported in December 2019. The new coronavirus is one of the highly pathogenic viruses affecting humans. To defeat this disease, it is necessary to form a collective immunity, which occurs due to the development of immunity in the population, either as a result of vaccination or as a result of a previous infection. Due to the high mortality rate and rapid spread, an effective vaccine is urgently needed to combat this pandemic. Vaccination of a significant part of the population will be required to safely achieve collective immunity against COVID-19, which will reduce the total amount of the virus that can spread among the entire population. One of the goals of vaccinating the population is to provide safety and protection against this disease for vulnerable populations who cannot be vaccinated.
Objective: to determine the attitude of Almaty city population to vaccination and readiness for its implementation by means of a survey among the adult population of Almaty.
Materials and methods: we conducted an online survey among the adult population of Almaty in the period from March 13 to 23, in which 263 people took part. The questionnaire included 17 questions. Next, we studied the characteristics of the survey participants (gender, age, education) and their attitude to vaccination, the reasons to accept or reject a vaccination.
Results: it was revealed that three-quarters of the population of Almaty is not ready to be vaccinated against coronavirus infection. The main reasons of rejection are lack of knowledge of the vaccine effect and the fear of possible side effects.
Dina G. Kussainova1, https://orcid.org/0000-0001-6533-3322, Anastasiya A. Shabanova1, Aigerim Begatar1, Sulkhi A. Jamalov1, Ayazhan U. Shatyrkhan1
1 Kazakh National Medical University named after S.D. Asfenfiyarov, Almaty c., Republic of Kazakhstan.
1. Вступительное слово Генерального директора на пресс брифинге по COVID-19 11 марта 2020 г. World Health Organization URL: https://www.who.int/ru/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 (Дата обращения: 21.03.2021).
2. Заявление по итогам второго совещания Комитета по чрезвычайной ситуации в соответствии с Международными медико-санитарными правилами, в связи со вспышкой заболевания, вызванного новым коронавирусом 2019 г. World Health Organization. URL: https://www.who.int/ru/news/item/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov) (Дата обращения: 21.03.2021)
3. Каждая десятая перспективная разработка вакцины от COVID-19 в мире оказалась российской. Интерфакс (24.04.2020). URL: https://www.interfax.ru/russia/705824 (Дата обращения: 23.03.2021)
4. Минздрав России зарегистрировал первую в мире вакцину от COVID-19. Министерство здравоохранения РФ. URL: https://minzdrav.gov.ru/news/2020/08/11/14657-minzdrav-rossii-zaregistriroval-pervuyu-v-mire-vaktsinu-ot-covid-19 (Дата обращения: 23.03.2021).
5. Национальный центр экспертизы лекарственных средств и медицинских изделий. URL: https://www.ndda.kz/pages/v-kazakhstane-nachalas-vaktsinatsiya-protiv-koronavirusa-o-chem-nuzhno-znat_1612349687 (Дата обращения: 23 марта 2021).
6. Ранее неизвестный коронавирус - Китай // World health organization. URL: https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/ru/ (Дата обращения: 20.03.2021).
7. Ситуация с коронавирусом официально. URL: https://www.coronavirus2020.kz/ (Дата обращения: 25.03.2021).
8. Шеян Н.Е. Международный опыт разработки вакцины от COVID-19. // Медицина. Социология. Философия. Прикладные исследования. 2020. №6. С. 41-43. URL: https://cyberleninka.ru/article/n/mezhdunarodnyy-opyt-razrabotki-vaktsiny-ot-covid-19/viewer
9. Baj J. et al. COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge // Journal of Clinical Medicine. 2020. №9(6). С. 1753. URL: https://www.ncbi.nlm.nih.gov/pmc/articles-/PMC7356953/
10. Baraniuk C. Covid-19: How the UK vaccine rollout delivered success, so far // BMJ. 2021. №372. С. 421. URL: https://www.bmj.com/content/372/bmj.n421
11. CanSino's COVID-19 vaccine approved for military use in China // Nikkei Asia URL: https://asia.nikkei.com/Business/Pharmaceuticals-/CanSino-s-COVID-19-vaccine-approved-for-military-use-in-China (Дата обращения: 29.06.2020).
12. Chaolin Huang, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China // Lancet. 2020. №395. С. 497—506. URL: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30183-5/fulltext
13. Coronavirus (COVID-19) Vaccinations – Statistics and Research // Our World in Data. (Дата обращения: 27.03. 2021). URL: https://ourworldindata.org/covid-vaccinations
14. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU) // ArcGIS. Johns Hopkins University URL: https://coronavirus.jhu.edu/map.html (Дата обращения: 20.03.2021).
15. Devlin. Hopes rise over experimental drug's effectiveness against coronavirus, The Guardian. URL: https://www.theguardian.com/world/-2020/mar/10/hopes-rise-over-experimental-drugs-effectiveness-against-coronavirus (Дата обращения: 19.03.2020).
16. Lurie N. et al. Developing Covid-19 vaccines at pandemic speed // New England Journal of Medicine. - 2020. №382(21). С. 1969–1973. URL: https://www.nejm.org/doi/full/10.1056/NEJMp2005630
17. Mi B. et al. Characteristics and Early Prognosis of COVID-19 Infection in Fracture Patients // The Journal of Bone and Joint Surgery. 2020. №102. p. 750–758. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7219849/
18. Plans P., et al. Lack of herd immunity against measles in individuals aged <35 years could explain re-emergence of measles in Catalonia (Spain) // International Journal of Infectious Diseases. 2014. №18. pp. 81-83. URL: https://pubmed.ncbi.nlm.nih.gov/24211476/
19. Plans-Rubió P. The vaccination coverage required to establish herd immunity against influenza viruses // Journal of Preventive Medicine and Public Health. 2012. №55. pp. 72–77. URL: https://pubmed.ncbi.nlm.nih.gov/22414740/
20. Qian G. et al. Epidemiologic and clinical characteristics of 91 hospitalized patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series // An International Journal of Medicine. - 2020. URL: https://pubmed.ncbi.nlm.nih.gov/32181807/
21. Randolph H.E., Barreiro L.B. Herd immunity: understanding COVID-19 // Immunity. 2020. №52. С. 737-741. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236739/
22. Reiter P.L. et al. Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated? // Vaccine. 2020. №38 (42). - С. 6500-6507. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440153/
23. Semenova Y. et al. Characteristics and Forecast of COVID-19 Outbreak in the Republic of Kazakhstan. // The Journal of Korean Medical Science. 2020. №35(24). pp. 227-236. URL: https://jkms.org/DOIx.php?id=10.3346/jkms.2020.35.e227
24. Severe acute respiratory syndrome coronavirus 2 isolate Wuhan-Hu-1, complete genome. NCBI reference sequence: NC_045512.2 URL: https://www.ncbi.nlm.nih.-gov/nuccore/NC_045512 (Дата обращения: 21.03.2021).
25. Tomasz M. et al. The 2020 race towards SARS-CoV-2 specific vaccines // Theranostics. 2021. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778607/
26. Wang D. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China // Jama. 2020. №323. С. 1061–1069. URL: https://jamanetwork.com/journals/-jama/fullarticle/2761044
27. Wang M. et al. Clinical diagnosis of 8274 samples with 2019-novel coronavirus in Wuhan // MedRxiv. 2020. URL: https://www.medrxiv.org/content/10.1101/2020.02.-12.20022327v2
28. Yoo J.H. What We Do Know and Do Not Yet Know about COVID-19 Vaccines as of the Beginning of the Year 2021 // Journal of Korean Medical Science. 2021. №36 (6). С. 54. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870421/
29. Zhang J.J. et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China // Allergy. 2020. №75. С. 1730–1741. URL: https://pubmed.ncbi.nlm.nih.gov/32077115/
References:
1. Vstupitel'noe slovo General'nogo direktora na press brifinge po COVID-19 11 marta 2020 g. [Opening remarks by the Director-General at a press briefing on COVID-19 March 11, 2020] World Health Organization URL: https://www.who.int/ru/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-11-march-2020. (accessed: 21.03.2021). [in Russian]
2. Zayavlenie po itogam vtorogo soveshchaniya Komiteta po chrezvychainoi situatsii v sootvetstvii s Mezhdunarodnymi mediko-sanitarnymi pravilami, v svyazi so vspyshkoi zabolevaniya, vyzvannogo novym koronavirusom 2019g. [Statement following the second meeting of the International Health Regulations Emergency Committee on the 2019 novel coronavirus outbreak]. World Health Organization URL: https://www.who.int/ru/-news/item/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov) (accessed: 21.03.2021). [in Russian]
3. Kazhdaya desyataya perspektivnaya razrabotka vaktsiny ot COVID-19 v mire okazalas' rossiiskoi. Interfaks (24.03.2020). [Every tenth promising development of a vaccine against COVID-19 in the world turned out to be Russian. Interfax (24.04.2020).] URL: https://www.interfax.ru/russia/705824 (Accessed: 23.03. 2021). [in Russian]
4. Minzdrav Rossii zaregistriroval pervuyu v mire vaktsinu ot COVID-19. Ministerstvo zdravookhraneniya RF [The Russian Ministry of Health has registered the world's first COVID-19 vaccine. Ministry of Health of the Russian Federation] URL: https://minzdrav.gov.ru/news/2020/08/11/14657-minzdrav-rossii-zaregistriroval-pervuyu-v-mire-vaktsinu-ot-covid-19 (Accessed: 23.03 2021). [in Russian]
5. Natsional'nyi tsentr ekspertizy lekarstvennykh sredstv i meditsinskikh izdelii [National Center for Expertise of Medicines and Medical Devices]. URL: https://www.ndda.kz/pages/v-kazakhstane-nachalas-vaktsinatsiya-protiv-koronavirusa-o-chem-nuzhno-znat_1612349687 (accessed: 23.03.2021). [in Russian]
6. Ranee neizvestnyi koronavirus — Kitai [Previously unknown coronavirus - China]. World health organization. Режим доступа: https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/ru/ (accessed: 20.03.2021). [in Russian]
7. Situatsiya s koronavirusom ofitsial'no [The situation with the coronavirus officially]. URL: https://www.coronavirus2020.kz/ (accessed: 25.03.2021) [in Russian]
8. Sheyan N.E. Mezhdunarodnyi opyt razrabotki vaktsiny ot COVID-19 [International experience in developing a vaccine against COVID-19]. Meditsina. Sotsiologiya. Filosofiya. Prikladnye issledovaniya [Medicine. Sociology. Philosophy. Applied research]. 2020. №6. pp. 41-43. URL: https://cyberleninka.ru/article/n/mezhdunarodnyy-opyt-razrabotki-vaktsiny-ot-covid-19/viewer (accessed: 25.03.2021) [in Russian]
9. Baj J. et al. COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge. Journal of Clinical Medicine. 2020. №9(6). pp. 1753. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356953/
10. Baraniuk C. Covid-19: How the UK vaccine rollout delivered success, so far. BMJ. 2021. №372. С. 421. URL: https://www.bmj.com/content/372/bmj.n421
11. CanSino's COVID-19 vaccine approved for military use in China. Nikkei Asia. URL: https://asia.nikkei.com/Business/Pharmaceuticals/CanSino-s-COVID-19-vaccine-approved-for-military-use-in-China (accessed: 29.06.2020)
12. Chaolin Huang, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020. №395. pp. 497-506. URL: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30183-5/fulltext
13. Coronavirus (COVID-19) Vaccinations – Statistics and Research. Our World in Data. (accessed: 27.03.2021). URL: https://ourworldindata.org/covid-vaccinations
14. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). ArcGIS. Johns Hopkins University URL: https://coronavirus.jhu.edu/map.html (accessed: 20.03.2021).
15. Devlin. Hopes rise over experimental drug's effectiveness against coronavirus. The Guardian. URL: https://www.theguardian.com/world/2020/mar/10/hopes-rise-over-experimental-drugs-effectiveness-against-coronavirus (accessed 19.03.2020).
16. Lurie N. et al. Developing Covid-19 vaccines at pandemic speed. New England Journal of Medicine. 2020. №382(21). pp. 1969–1973. URL: https://www.nejm.org/doi/full/10.1056/NEJMp2005630
17. Mi B. et al. Characteristics and Early Prognosis of COVID-19 Infection in Fracture Patients. The Journal of Bone and Joint Surgery. 2020. №102. pp. 750–758. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7219849/
18. Plans P. et al. Lack of herd immunity against measles in individuals aged <35 years could explain re-emergence of measles in Catalonia (Spain). International Journal of Infectious Diseases. 2014. №18. pp. 81-83. URL: https://pubmed.ncbi.nlm.nih.gov/24211476/
19. Plans-Rubió P. The vaccination coverage required to establish herd immunity against influenza viruses. Journal of Preventive Medicine and Public Health. 2012. №55. pp. 72–77. URL: https://pubmed.ncbi.nlm.nih.gov/22414740/
20. Qian G. et al. Epidemiologic and clinical characteristics of 91 hospitalized patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series. An International Journal of Medicine. 2020. URL: https://pubmed.ncbi.nlm.nih.gov/32181807/
21. Randolph H.E., Barreiro L.B. Herd immunity: understanding COVID-19. Immunity. 2020. №52. С. 737-741. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236739/
22. Reiter P.L. et al. Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated? Vaccine. 2020. №38 (42). - pp. 6500 - 6507. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440153/
23. Semenova Y. et al. Characteristics and Forecast of COVID-19 Outbreak in the Republic of Kazakhstan. The Journal of Korean Medical Science. 2020. №35(24). С. 227-236. URL: https://jkms.org/DOIx.php?id=10.3346/jkms.2020.35.e227
24. Severe acute respiratory syndrome coronavirus 2 isolate Wuhan-Hu-1, complete genome. NCBI reference sequence: NC_045512.2. URL: https://www.ncbi.nlm.nih.gov/nuccore/NC_045512 (accessed: 21.03.2021)
25. Tomasz M. et al. The 2020 race towards SARS-CoV-2 specific vaccines. Theranostics. 2021. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778607/
26. Wang D. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. Jama. 2020. №323. pp. 1061–1069. URL: https://jamanetwork.com/journals/jama/fullarticle/2761044
27. Wang M. et al. Clinical diagnosis of 8274 samples with 2019-novel coronavirus in Wuhan. MedRxiv. 2020. URL: https://www.medrxiv.org/content/10.1101/2020.02.12.20022327v2
28. Yoo J.H. What We Do Know and Do Not Yet Know about COVID-19 Vaccines as of the Beginning of the Year 2021. Journal of Korean Medical Science. 2021. №36 (6). pp. 54. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870421/
29. Zhang J.J. et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020. №75. pp. 1730–1741. URL:: https://pubmed.ncbi.nlm.nih.gov/32077115/
Number of Views: 172
Category of articles:
COVID-19 - Topical Subject
Bibliography link
Kussainova D.G., Shabanova A.A., Begatar A., Jamalov S.A., Shatyrkhan A.U. Predicted assessment of the commitment of Almaty city’s population to vaccination against SARS-CoV-2 // Nauka i Zdravookhranenie [Science & Healthcare]. 2021, 2 (Vol.23), pp. 6-12. doi 10.34689/SH.2021.23.2.001Related publications:
IMMUNOLOGICAL CHANGES IN CHILDREN WITH MULTISYSTEM INFLAMMATORY SYNDROME ASSOCIATED WITH SARS-COV-2
EFFICACY OF THE ANTIVIRAL DRUG ENISAMY IODIDE IN SEVERE ADULT ACUTE RESPIRATORY INFECTIONS IN THE COVID-19 ERA
APPLICATION OF ARTIFICIAL INTELLIGENCE IN COMBATING THE COVID-19 PANDEMIC: CURRENT TRENDS AND PROSPECTS. REVIEW
CONSEQUENCES OF THE CORONAVIRUS INFECTION: THE POST-COVID SYNDROME AND MENTAL MANIFESTATIONS. LITERATURE REVIEW
FEATURES OF THE SICKNESS BEHAVIOR OF ARTERIAL HYPERTENSION AND OBESITY DURING THE PANDEMIC OF COVID-19 CORONAVIRUS. REVIEW